By Debdeep Gupta | 09 Feb, 2024
Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in Australia
Biocon Biologics inks pact with Sandoz for sale of 2 biosimilar products in AustraliaThe agreement provides Sandoz the exclusive rights to promote, sell and distribute biosimilars Trastuzumab and Bevacizumab in Australia, Biocon Biologics said in a statement.Biocon Biologics on Friday said it has inked a five-year pact with pharmaceutical company Sandoz AG regarding the sale and distribution of tw...
Live Comments